| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |